Cargando…
Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase
The liver toxicity of valproic acid (VPA) is an established side effect of this widely used antiepileptic drug, which is extremely problematic for patients with metabolic epilepsy and particularly epilepsy due to mitochondrial dysfunction. In the present report, we investigated the reason for liver...
Autores principales: | Kudin, Alexei P., Mawasi, Hafiz, Eisenkraft, Arik, Elger, Christian E., Bialer, Meir, Kunz, Wolfram S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618561/ https://www.ncbi.nlm.nih.gov/pubmed/28878165 http://dx.doi.org/10.3390/ijms18091912 |
Ejemplares similares
-
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions
por: Ginn, John, et al.
Publicado: (2021) -
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium
por: Chang, Pishan, et al.
Publicado: (2012) -
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
por: Chateauvieux, Sébastien, et al.
Publicado: (2010) -
Severe Hyponatremia Due to Valproic Acid Toxicity
por: Gupta, Ena, et al.
Publicado: (2015) -
Thrombotic microangiopathy associated with Valproic acid toxicity
por: Hebert, Sean A., et al.
Publicado: (2017)